CLINICAL_TRIALS
ClinicalTrials.gov record update
A Phase I Proof-of-Concept Study of Artesunate Ointment for the Treatment of Patients With High-Grade Vulvar Intraepithelial Neoplasia (HSIL VIN 2/3)
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT03792516
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-25T22:27:05.489814+00:00
- Published At
- 2024-12-04T00:00:00+00:00
- Record Updated At
- 2024-12-04
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Vulvar Dysplasia", "HPV-Related Vulvar Intraepithelial Neoplasia", "Preinvasive Vulvar Disease", "Vulva Intraepithelial Neoplasia", "Vulvar Diseases"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2024-12-04"- protocolSection.identificationModule.nctId
"NCT03792516"- protocolSection.identificationModule.officialTitle
"A Phase I Proof-of-Concept Study of Artesunate Ointment for the Treatment of Patients With High-Grade Vulvar Intraepithelial Neoplasia (HSIL VIN 2/3)"- protocolSection.statusModule.overallStatus
"COMPLETED"- protocolSection.designModule.phases
["PHASE1"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.